Allison Dipasquale, M.D.
Surgical Oncology Physician · Dallas, TX
Allison Dipasquale, M.D. is a surgical oncology physician with a practice address in Dallas, Texas, and NPI 1003045386, issued on Jul 8, 2009. Check the license (Texas Q4387, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Allison Dipasquale
- Credential
- M.D.
- Primary taxonomy
- Surgical Oncology Physician 2086X0206X
- License numbers
- Q4387 TX
A130790 CA
Self-reported in NPPES; status is on the state search - Practice location
- 7777 Forest LN Ste C614, Dallas, TX 75230
- Phone
- (972) 566-7499
- Enumerated
- Jul 8, 2009
- Record last updated
- Aug 19, 2022
- Fax
- (972) 566-6428
- Medicaid IDs
- 348566604 TX
348566602 TX
348566601 TX - Medicare enrollment
- Enrolled (PECOS I20150821012724); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest surgical oncology physician records → All 206 in Texas → Look up another NPI →
Also registered at 7777 Forest LN Ste C614
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Margarethe Bryant, RN, CNOR, RNFARegistered Nurse First Assistant1992464234
- Sheryl Mayer, CRNFARegistered Nurse First Assistant1578625059
- Kristi McIntyre, RNFARegistered Nurse First Assistant1154834299
Verify Allison Dipasquale in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license Q4387Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
2.4 times the Medicare Part D claims of the average surgical oncology physician in 2024
213 Medicare Part D claims for 103 beneficiaries, against an average of 87 among the 1,237 providers of this specialty who prescribed in Part D. Brand-name drugs were 0% of claims. 49 claims were for opioids.
Most prescribed
- Anastrozole106 claims
- Cephalexin30 claims
- Tramadol Hcl25 claims
- Acetaminophen-Codeine23 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $68,038.48
38 payments; by number, the most common kind was consulting fee; the largest payer was Sirius Medical Systems. The 1,132 providers of this specialty with any payment received $4,224.74 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Texas Oncology PADallas, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Allison Dipasquale among 206 surgical oncology physician records in Texas
Allison Dipasquale, M.D. is one of 206 surgical oncology physician records with a practice address in Texas. 87% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2009, is newer than 60% of them.
- NPI issued2009 · 60% of these records are older, 35% newer
- In a Medicare fileYes · 87% of these records are
- In the CMS Doctors and Clinicians fileYes · 78% of these records are
- Graduated2009 · median 2005 among the 161 with a school on file
- Record last updated2022 · 46% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 2086X0206X and a Texas practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Surgical Oncology Physician providers in Texas
There are 206 surgical oncology physician records in Texas.
All 206 in Texas → Every provider in Dallas → Surgical Oncology Physician nationwide →
The 8 surgical oncology physician records with the nearest ZIP codes
- Christine Landry, MDDallas, TX 752301083742662
- William McNamara, M.D.Dallas, TX 752301720235427
- Peter Beitsch, M.D.Dallas, TX 752311336187731
- Archana Ganaraj, MDDallas, TX 752311336173475
- Carolyn Thomas, MDDallas, TX 752311366680860
- Cecilia EthunDallas, TX 752351013350214
- Danielle Jacobbe, D.O.Dallas, TX 752371922393669
- Tuoc Dao, M.D.Dallas, TX 752461295938462
Common questions
What is Allison Dipasquale, M.D.'s NPI number?
Allison Dipasquale, M.D.'s National Provider Identifier (NPI) is 1003045386, issued on Jul 8, 2009. An NPI identifies a provider in billing; it is not a license.
Where is Allison Dipasquale, M.D. located?
The NPPES record lists a practice address at 7777 Forest LN Ste C614, Dallas, TX, 75230. Phone: (972) 566-7499. Providers update this record themselves, so call before visiting.
How can I verify Allison Dipasquale, M.D.'s license?
NPPES lists Texas license number Q4387, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Allison Dipasquale, M.D. prescribe under Medicare Part D?
In 2024, Allison Dipasquale, M.D. had 213 Medicare Part D claims for 103 beneficiaries; the average among surgical oncology physician prescribers was 87. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.